Increased cardiovascular risk in patients with rheumatoid arthritis: an overview

被引：18

作者：

Puttevils, Daisy ^{[1
]}

De Vusser, Philip ^{[2
]}

Geusens, Piet ^{[3
]}

Dens, Jo ^{[2
]}

机构：

[1] Leuven Univ Hosp, Dept Cardiol, B-3000 Leuven, Belgium

[2] Ziekenhuis Oost Limburg, Dept Cardiol, Genk, Belgium

[3] Netherlands & Univ Hasselt, Maastricht Univ Med Ctrdep, Dept Rheumatol, Hasselt, Belgium

来源：

ACTA CARDIOLOGICA | 2014年 / 69卷 / 02期

关键词：

Cardiovascular risk; atherogenesis; rheumatoid arthritis; TNF antagonists; heart failure; NECROSIS-FACTOR-ALPHA; CONGESTIVE-HEART-FAILURE; IMPROVES ENDOTHELIAL FUNCTION; C-REACTIVE PROTEIN; CAUSE-SPECIFIC MORTALITY; LONG-TERM TREATMENT; ANTI-TNF THERAPY; INSULIN-RESISTANCE; INFLAMMATORY POLYARTHRITIS; MYOCARDIAL-INFARCTION;

D O I：

10.1080/AC.69.2.3017291

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Patients with established rheumatoid arthritis (RA) have a higher cardiovascular morbidity and mortality in comparison with the general population. It is considered to be an independent risk factor for cardiovascular disease. The purpose of this article is to describe the mechanisms responsible for accelerated atherogenesis in RA patients and to give an overview of the effects of different RA therapies (methotrexate, TNF antagonists and other biologicals).

引用

页码：111 / 118

页数：8

共 91 条

[31] Short-Term Improvement of Endothelial Function in Rituximab-Treated Rheumatoid Arthritis Patients Refractory to Tumor Necrosis Factor α Blocker Therapy [J].

Gonzalez-Juanatey, Carlos ;

Llorca, Javier ;

Vazquez-Rodriguez, Tomas R. ;

Diaz-Varela, Nicolas ;

Garcia-Quiroga, Hermitas ;

Gonzalez-Gay, Miguel A. .

ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2008, 59 (12) :1821-1824

[32] Baseline levels of C-reactive protein and prediction of death from cardiovascular disease in patients with inflammatory polyarthritis - A ten-year followup study of a primary care-based inception cohort [J].

Goodson, NJ ;

Symmons, DPM ;

Scott, DGI ;

Bunn, D ;

Lunt, M ;

Silman, AJ .

ARTHRITIS AND RHEUMATISM, 2005, 52 (08) :2293-2299

[33] Mortality in early inflammatory polyarthritis - Cardiovascular mortality is increased in seropositive patients [J].

Goodson, NJ ;

Wiles, NJ ;

Lunt, M ;

Barrett, EM ;

Silman, AJ ;

Symmons, DPM .

ARTHRITIS AND RHEUMATISM, 2002, 46 (08) :2010-2019

[34]

Han CL, 2006, J RHEUMATOL, V33, P2167

[35] IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance [J].

Hotamisligil, GS ;

Peraldi, P ;

Budavari, A ;

Ellis, R ;

White, MF ;

Spiegelman, BM .

SCIENCE, 1996, 271 (5249) :665-668

[36] Anti-tumor necrosis factor-α treatment improves endothelial function in patients with rheumatoid arthritis [J].

Hürlimann, D ;

Forster, A ;

Noll, G ;

Enseleit, F ;

Chenevard, R ;

Distler, O ;

Béchir, M ;

Spieker, LE ;

Neidhart, M ;

Michel, BA ;

Gay, RE ;

Lüscher, TF ;

Gay, S ;

Ruschitzka, F .

CIRCULATION, 2002, 106 (17) :2184-2187

[37]

Jacobsson LTH, 2005, J RHEUMATOL, V32, P1213

[38] Cardiovascular disease in rheumatoid arthritis [J].

Kaplan, Mariana J. .

CURRENT OPINION IN RHEUMATOLOGY, 2006, 18 (03) :289-297

[39]

Kiortsis DN, 2006, J RHEUMATOL, V33, P921

[40] C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men -: Results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992 [J].

Koenig, W ;

Sund, M ;

Fröhlich, M ;

Fischer, HG ;

Löwel, H ;

Döring, A ;

Hutchinson, WL ;

Pepys, MB .

CIRCULATION, 1999, 99 (02) :237-242

← 1 2 3 4 5 6 7 8 9 10 →